Krystal Biotech Inc (KRYS)
Return on assets (ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 89,159 | 52,372 | 105,939 | 57,161 | 10,932 | -29,812 | -140,409 | -135,307 | -139,975 | -129,729 | -115,468 | -103,723 | -69,570 | -58,147 | -52,168 | -42,638 | -32,167 | -27,141 | -21,803 | -20,318 |
| Total assets | US$ in thousands | 1,055,840 | 982,318 | 917,658 | 853,296 | 818,355 | 790,350 | 684,026 | 531,847 | 558,450 | 576,379 | 601,324 | 616,874 | 626,295 | 451,095 | 443,556 | 443,018 | 310,844 | 311,451 | 318,145 | 205,131 |
| ROA | 8.44% | 5.33% | 11.54% | 6.70% | 1.34% | -3.77% | -20.53% | -25.44% | -25.06% | -22.51% | -19.20% | -16.81% | -11.11% | -12.89% | -11.76% | -9.62% | -10.35% | -8.71% | -6.85% | -9.90% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $89,159K ÷ $1,055,840K
= 8.44%
Krystal Biotech Inc's return on assets (ROA) experienced significant fluctuations over the past five years. The trend shows a consistent decrease in ROA from March 2022 to March 2023, reaching the lowest point of -25.44%. This indicates that the company's ability to generate profits from its assets was severely impacted during this period.
However, starting from September 2023, there was a notable improvement in ROA, with the percentage increasing to 1.34% by December 2023. This positive trend continued into the following years, with the ROA rising to 11.54% by June 2024 and further to 8.44% by December 2024. These improvements suggest that Krystal Biotech Inc was able to enhance its efficiency in generating profits from its assets and potentially improved its overall financial performance during this period.
Overall, the analysis of Krystal Biotech Inc's ROA indicates a volatile performance trend, with significant fluctuations but a recent positive momentum in utilizing its assets to generate returns. Continued monitoring of ROA will be essential to assess the company's financial health and operational efficiency in the future.
Peer comparison
Dec 31, 2024